MYHEALTHCHECKED PLC

Regulatory Filings • Jul 17, 2025

National Storage Mechanism | Additional information

RNS Number : 3841R

MyHealthChecked PLC

17 July 2025

MyHealthChecked PLC

( " MyHealthChecked " or the "Company " )

Supply agreement with Boots for own-branded tests

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that it has signed a supply agreement with Boots UK Ltd ("Boots") to supply a range of lateral flow self-tests and laboratory tests under the Boots' Own Brand label.

The contract, with an initial term of 12 months, covers a range comprising eight blood tests, one DNA test, and four lateral flow self-tests, which will be launched by Boots in August 2025.

Penny McCormick, Chief Executive Officer of  MyHealthChecked PLC , said:  "We're delighted to have secured this supply into Boots in the expansion of its range of own brand wellness tests. We have developed a strong working and commercial relationship with Boots over the past four years, and we're excited to see this continue."

For further information contact:

MyHealthChecked plc			www.myhealthchecked.com
P enny McCormick, Chief Executive Officer			via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)			Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker)		Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
Paul McManus / Alice Woodings		Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGRGPUQWMUPAGMQ